This particular conjugate exhibited enhanced biological performance: it demonstrated selective uptake in EGFR-positive cancer cell lines (HT29 and HCT116), while minimal uptake was observed in EGFR-negative lines (HeLa and HEK293). The gene discussed is EGFR; the disease is cancer.